Alnylam Pharmaceuticals (ALNY)
(Delayed Data from NSDQ)
$150.31 USD
+0.35 (0.23%)
Updated May 2, 2024 04:00 PM ET
After-Market: $150.08 -0.23 (-0.15%) 7:58 PM ET
3-Hold of 5 3
D Value A Growth A Momentum B VGM
Key Expected Earnings Data
Report Date | Period Ending | Zacks Consensus Estimate | Earnings ESP |
---|---|---|---|
08/01/2024
Time: BMO |
6/2024 | $-0.72 | -27.78% |
Earnings Summary
For their last quarter, Alnylam Pharmaceuticals (ALNY) reported earnings of -$0.16 per share, beating the Zacks Consensus Estimate of $-0.75 per share. This reflects a positive earnings surprise of 78.67%. Look out for ALNY's next earnings release expected on August 01, 2024. For the next earning release, we expect the company to report earnings of -$0.72 per share, reflecting a year-over-year increase of 46.43%.
Earnings History
Price & Consensus
Zacks News for ALNY
Alnylam Pharmaceuticals (ALNY) Reports Q1 Loss, Tops Revenue Estimates
ALNY: What are Zacks experts saying now?
Zacks Private Portfolio Services